v3.25.4
Other Financial Information (Details) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Incurred      
Debt $ 997 $ 919 $ 842
Other 63 9 86
Total incurred 1,060 928 928
Capitalized (21) (21) (31)
Expensed 1,039 907 897
Other Income      
Interest income 141 158 269
Unrealized investment loss—NOVONIX (12) 0 (38)
Other, net 312 85 128
Other Income 438 243 359
Research and Development Expenses 6 15 27
Advertising Expenses 62 51 54
Foreign Currency Transaction (Gains) Losses (1) 11 22
Corporate and Other      
Incurred      
Expensed 1,039 907 897
Other Income      
Interest income 141 158 269
Other Income 154 186 259
Foreign Currency Transaction (Gains) Losses 12 6 (2)
Midstream      
Other Income      
Foreign Currency Transaction (Gains) Losses 0 0 0
Chemicals      
Other Income      
Foreign Currency Transaction (Gains) Losses 0 0 0
Refining      
Other Income      
Foreign Currency Transaction (Gains) Losses (21) 0 19
Marketing and Specialties      
Other Income      
Foreign Currency Transaction (Gains) Losses 2 3 2
Renewable Fuels      
Other Income      
Foreign Currency Transaction (Gains) Losses 6 2 3
NOVONIX      
Other Income      
Unrealized investment loss—NOVONIX $ (15) $ 0 $ (38)